Sage Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.6M | 76k | 21.67 |
| 2023-09-30 | $1.6M | 76k | 20.58 |
| 2023-06-30 | $3.5M | 75k | 47.02 |
| 2023-03-31 | $3.6M | 86k | 41.96 |
| 2022-12-31 | $3.2M | 84k | 38.14 |
| 2022-09-30 | $3.2M | 83k | 39.16 |
| 2022-06-30 | $2.5M | 77k | 32.30 |
| 2022-03-31 | $1.4M | 42k | 33.10 |
| 2021-12-31 | $2.0M | 48k | 42.53 |
| 2021-09-30 | $2.1M | 48k | 44.31 |
| 2021-06-30 | $3.0M | 52k | 56.80 |
| 2021-03-31 | $4.1M | 55k | 74.85 |
| 2020-12-31 | $5.0M | 58k | 86.51 |
| 2020-09-30 | $3.5M | 57k | 61.12 |
| 2020-06-30 | $2.4M | 58k | 41.58 |
| 2020-03-31 | $1.5M | 51k | 28.72 |
| 2019-12-31 | $3.8M | 52k | 72.20 |
| 2019-09-30 | $7.1M | 51k | 140.29 |
| 2019-06-30 | $9.3M | 51k | 183.09 |
| 2019-03-31 | $7.7M | 49k | 159.05 |
| 2018-12-31 | $4.5M | 47k | 95.79 |
| 2018-09-30 | $6.8M | 48k | 141.26 |
| 2018-06-30 | $7.7M | 49k | 156.53 |
| 2018-03-31 | $6.6M | 41k | 161.08 |
| 2017-12-31 | $6.3M | 39k | 164.72 |
| 2017-09-30 | $2.6M | 42k | 62.31 |
| 2017-06-30 | $3.3M | 41k | 79.63 |
| 2017-03-31 | $2.7M | 38k | 71.06 |
| 2016-12-31 | $1.8M | 36k | 51.07 |
| 2016-09-30 | $1.3M | 29k | 46.07 |
| 2016-06-30 | $733k | 24k | 30.12 |
| 2016-03-31 | $490k | 15k | 32.05 |
| 2015-12-31 | $789k | 14k | 58.29 |
| 2015-09-30 | $514k | 12k | 42.29 |
| 2015-06-30 | $848k | 12k | 73.04 |